Whitworth Kristen, Johnson Jacob, Wisniewski Samuel, Schrader Meghan
Lakeland Health, United States.
Michigan State University College of Osteopathic Medicine, United States.
Data Brief. 2020 Feb 13;29:105283. doi: 10.1016/j.dib.2020.105283. eCollection 2020 Apr.
The use of tranexamic acid (TXA) has recently gained popularity as a treatment modality for epistaxis in the emergency department. Data are presented on the efficacy of the topical use of the intravenous formulation of TXA versus the vasoconstrictor oxymetazoline applied topically in achieving hemostasis in patient presenting to the emergency department with anterior epistaxis. The original article "Comparative Effectiveness of Topically Administered TXA Versus Topical Oxymetazoline Spray for Achieving Hemostasis in Epistaxis" [1] provides complete interpretation of the data. The dataset regarding these treatment modalities has clinical significance toward preventing an avoidable need for escalation of treatment that could potentially increase patient discomfort and prolong emergency department throughput time.
氨甲环酸（TXA）作为急诊科鼻出血的一种治疗方式，近来受到广泛应用。本文呈现了静脉用TXA局部应用与局部应用血管收缩剂羟甲唑啉在急诊科前位鼻出血患者止血效果的数据对比。原文《局部应用TXA与局部应用羟甲唑啉喷雾剂治疗鼻出血的止血效果比较》[1]对这些数据进行了完整解读。关于这些治疗方式的数据集对于避免不必要的治疗升级具有临床意义，这种升级可能会增加患者不适并延长急诊科的就诊时间。
